| 摘要 |
Reagents that regulate human secretin-type GPCR (latrophilin) and reagents which bind to human secretin-type GPCR (latrophilin) gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, diabetes, obesity, cardiovascular disorders, gastrointestinal disorders, CNS disorders, hematological disorders, genitourological disorders, and cancer.
|
